Scleroderma News and Research

Latest Scleroderma News and Research

Cyclophosphamide may be a possible therapy for scleroderma

A drug that suppresses the immune system and reduces inflammation has been shown to be effective in treating lung disease associated with the devastating connective tissue disease scleroderma, according to results presented at the American Thoracic Society International Conference on May 23.

24 May 2005

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

Sildenafil is the active ingredient in Viagra, Pfizer's erectile dysfunction medication used by more than 23 million men worldwide.

4 Dec 2004

African Americans more likely to carry genetic variants known to stimulate inflammatory response

Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).

1 Dec 2004

No convincing evidence that breast implants effect development of connective tissue disorders

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, found no convincing evidence that breast implants have an effect on the development of subsequent connective tissue disorders (CTDs).

19 Oct 2004

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

An investigational new drug for pulmonary hypertension may improve the quality of life for thousands of patients with scleroderma, lupus, and other associated connective tissue diseases, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Antonio, Texas.

18 Oct 2004

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

More than 150,000 children in the United States are affected by rheumatic diseases such as juvenile rheumatoid arthritis, lupus, dermatomyositis, scleroderma, and systemic vasculitis.

10 Oct 2004

Study on the long-term health effects associated with silicone breast implants

It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.

23 Sep 2004

Scleroderma News and Research

Latest Scleroderma News and Research

Cyclophosphamide may be a possible therapy for scleroderma

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

African Americans more likely to carry genetic variants known to stimulate inflammatory response

No convincing evidence that breast implants effect development of connective tissue disorders

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

Study on the long-term health effects associated with silicone breast implants

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Scleroderma News and Research

Latest Scleroderma News and Research

Cyclophosphamide may be a possible therapy for scleroderma

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

African Americans more likely to carry genetic variants known to stimulate inflammatory response

No convincing evidence that breast implants effect development of connective tissue disorders

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

Study on the long-term health effects associated with silicone breast implants

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in